Clearwater medical device maker posts sales gains
March 14, 2019 - Apyx Medical Corp. (Nasdaq: APYX) had $16.7 million in revenue from continuing operations in 2018, up 63 percent from 2017. The loss from continuing operations was $9.5 million, compared a $13.7 million loss in 2017. Clearwater-based Apyx, formerly Bovie, sold its legacy business last year and now focuses on medical devices in the cosmetic and surgical markets.